Left Menu
Development News Edition

Russia to supply 100 million doses of COVID-19 vaccine to India's Dr. Reddy's Laboratories

The Russian Direct Investment Fund on Wednesday confirmed reaching an agreement to supply 100 million doses of Russian COVID-19 vaccine Sputnik V to India's Dr. Reddy's Laboratories.

ANI | Moscow | Updated: 16-09-2020 15:23 IST | Created: 16-09-2020 15:23 IST
Russia to supply 100 million doses of COVID-19 vaccine to India's Dr. Reddy's Laboratories
Representative image . Image Credit: ANI

The Russian Direct Investment Fund on Wednesday confirmed reaching an agreement to supply 100 million doses of Russian COVID-19 vaccine Sputnik V to India's Dr. Reddy's Laboratories. "The RDIF, Russia's sovereign wealth fund, and Dr. Reddy's Laboratories Ltd. (Dr. Reddy's), a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India. Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine," Sputnik quoted the RDIF's press release.

Deliveries could start in late 2020, the release added. GV Prasad, Co-Chairman and Managing Director of Dr. Reddy said that the Phase I and II trials results have shown promise, and the company will be conducting Phase III trials in India to meet the requirements of the Indian regulators.

"We are pleased to partner with RDIF to bring the vaccine to India. Phase I and II results have shown promise, and we will be conducting Phase III trials in India to meet the requirements of the Indian regulators. Sputnik V vaccine could provide a credible option in our fight against COVID 19 in India," Dr. Reddy's Co-Chairman and Managing Director GV Prasad said, as quoted in the press release. The RDIF is pleased to reach the agreement with the Indian company, the RDIF CEO Kirill Dmitriev said.

"Dr. Reddy's has had a very well established and respected presence in Russia for over 25 years and is one of the leading pharmaceutical companies in India," he said "India is amongst most severely impacted countries from the novel coronavirus and we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against COVID 19. RDIF partners will receive an effective and safe drug to fight the coronavirus," he added.

Last week, the Russian Health Ministry announced that the first batch of Sputnik V vaccine against COVID-19 has been released into civil circulation. The Russian health ministry registered the first vaccine against COVID-19, named Sputnik V, on August 11. (ANI)


TRENDING

OPINION / BLOG / INTERVIEW

Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...

Videos

Latest News

Arsenal's Mark McGuinness joins Ipswich Town on season-long loan

Arsenal on Tuesday announced that Mark McGuinness has joined League One side Ipswich Town on a season-long loan. Mark McGuinness has joined League One side Ipswich Town on loan until the end of the season, the club said in a statement.The 1...

France again reports over 10,000 new COVID-19 cases in a day

France again registered more than 10,000 new confirmed coronavirus infections over 24-hours, for the sixth time in 12 days.The health ministry reported 10,008 new cases on Tuesday, compared to 5,298 on Monday - which usually sees a dip due ...

U.S. health agency sets Oct. 16 deadline for states to submit vaccine plans

The U.S. Centers for Disease Control and Prevention CDC on Tuesday set an Oct. 16 deadline for states to submit plans for distributing COVID-19 vaccines - even before it becomes clear when any will be available - according to a presentation...

Czech Republic to limit public events as COVID-19 cases spike

The new Czech health minister said on Tuesday tighter restrictions on bars and public events were imminent after his predecessor resigned following a doubling of COVID-19 infections in the country over the past three weeks.The Czech Republi...

Give Feedback